戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ocus on molecular markers or analyze data in retrospect.
2 detected 3 other sites of metastasis only in retrospect.
3 or a probably benign lesion when reviewed in retrospect.
4         Of these, 286 had lesions visible in retrospect.
5 ceived antibiotics that were overly broad in retrospect.
6 rgence is rare and challenging to uncover in retrospect(3-5).
7                             We identified in retrospect all adult (>18 years of age) patients diagnos
8 regimens that were broader than necessary in retrospect, and 1 in 6 developed antibiotic-associated c
9  narrower antibiotics would have sufficed in retrospect, and possible antibiotic-associated complicat
10 ntibiotic courses are unnecessarily broad in retrospect, and whether these patterns are changing over
11 low-up MR imaging, five were identifiable in retrospect at initial MR studies (mean diameter, 1.4 cm)
12 e proportion that were likely unnecessary in retrospect based on the absence of beta-lactam resistant
13 re retrospectively identified that could, in retrospect, be identified on the previous CT scans (time
14 d a nodular lung cancer that was apparent in retrospect but had not been mentioned in the report.
15 ures of the global catalog are improbable in retrospect, but so are some features of most random sequ
16 thods or accrual of new observations that in retrospect can lead to lucid answers to the initial prob
17 up is often recommended for lesions that, in retrospect, do not fulfill established diagnostic criter
18 st discoveries usually become aggrandized in retrospect, especially at jubilee celebrations, and the
19  fail to take steps to halt behavior that in retrospect everyone judges reprehensible is complex.
20                                           In retrospect, failure of anti-CD4 Abs to induce tolerance
21                                           In retrospect, however, steady-state mRNA abundance levels
22                          A timely example in retrospect is the identification of immune signatures (c
23                                           In retrospect, it is not surprising that the polyhydroxylat
24   Here we show that there is another, and in retrospect more obvious path, which is through asynchron
25                                           In retrospect, none of these vascular lesions were evident
26 ad at early stages of infection, providing a retrospect of forces that shaped the complexity, archite
27            This review gives a comprehensive retrospect of the past century-long effort about the who
28                                           In retrospect over the past 30 years, advances in aptamer d
29 ic core were surprisingly challenging and in retrospect, presaged the many detours needed to ultimate
30                                              Retrospecting that, effort has been directed toward elec
31                                   Herein, we retrospect the history of 2D colloids and discuss about
32                                           In retrospect, the clinical phenotype in the family is cons
33                                           In retrospect, the donor's clinical presentation (which beg
34  2 criteria for operability to determine, in retrospect, the efficacy of preoperative testing in pati
35                                           In retrospect, the failure of MMPIs to alter disease progre
36                                           In retrospect, the literature often contains earlier hints
37 teristics were then used to determine if, in retrospect, the mammographic appearance met previously p
38                                           In retrospect, the three most important building blocks hav
39 y did not need hospitalization said that, in retrospect, they believed they had needed it.
40                                           In retrospect, this could occur at the level of receptor re
41 and binding domain, often identified only in retrospect, underlie different patterns of ligand bindin
42 election of specimens was consecutive and in retrospect using our register of the Vitreoretinal Patho
43 e evidence for each of these variants is, in retrospect, visible in srGS, they were either not called
44 erminal extensions of VP1 and VP2, which, in retrospect, were present in lower-resolution structures
45                                           In retrospect, when the analyses were completed, her UP-Sui
46        This hypothesis was then compared, in retrospect, with a known opinion established following a